Closone is developed by Seoul St. Mary's Hospital.

What development phase is Closone in?

Closone is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Closone

Seoul St. Mary's Hospital · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	Closone
Sponsor	Seoul St. Mary's Hospital
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin (PHASE4)
Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Closone CI brief — competitive landscape report
Closone updates RSS · CI watch RSS
Seoul St. Mary's Hospital portfolio CI